Article Versions Notes

Lescroart M, Pressiat C, Péquignot B, Tran N, Hébert J-L, Alsagheer N, Gambier N, Ghaleh B, Scala-Bertola J, Levy B. Impaired Pharmacokinetics of Amiodarone under Veno-Venous Extracorporeal Membrane Oxygenation: From Bench to Bedside. Pharmaceutics. 2022; 14(5):974. https://doi.org/10.3390/pharmaceutics14050974

Lescroart, Mickaël, Claire Pressiat, Benjamin Péquignot, N’Guyen Tran, Jean-Louis Hébert, Nassib Alsagheer, Nicolas Gambier, Bijan Ghaleh, Julien Scala-Bertola, and Bruno Levy. 2022. "Impaired Pharmacokinetics of Amiodarone under Veno-Venous Extracorporeal Membrane Oxygenation: From Bench to Bedside" Pharmaceutics 14, no. 5: 974. https://doi.org/10.3390/pharmaceutics14050974

Lescroart, M., Pressiat, C., Péquignot, B., Tran, N., Hébert, J.-L., Alsagheer, N., Gambier, N., Ghaleh, B., Scala-Bertola, J., & Levy, B. (2022). Impaired Pharmacokinetics of Amiodarone under Veno-Venous Extracorporeal Membrane Oxygenation: From Bench to Bedside. Pharmaceutics, 14(5), 974. https://doi.org/10.3390/pharmaceutics14050974